<?xml version="1.0" encoding="UTF-8"?>
<eudamedExport entity="devices">
  <row>
    <udiDi>D-70-SS-bTECKAA</udiDi>
    <basicUdiDi>B-70-SS-bTECKAA</basicUdiDi>
    <tradeName>TLA GUT (UC)</tradeName>
    <deviceName>TLA GUT</deviceName>
    <manufacturerName>TLA Targeted Immunotherapies AB</manufacturerName>
    <manufacturerSrn>SE-MF-000039975</manufacturerSrn>
    <authorisedRepresentativeName></authorisedRepresentativeName>
    <authorisedRepresentativeSrn></authorisedRepresentativeSrn>
    <riskClass>Sınıf IIb</riskClass>
    <legislation>MDD</legislation>
    <emdnCode>B030299</emdnCode>
    <emdnDescription>APHERESIS THERAPY DEVICES - OTHER</emdnDescription>
    <deviceStatus>Piyasada</deviceStatus>
    <reference>00170-SS-bTECK</reference>
    <placedOnMarketCountry>Sweden</placedOnMarketCountry>
    <lastUpdated>2026-07-17T01:28:22.541Z</lastUpdated>
  </row>
  <row>
    <udiDi>14993478010103</udiDi>
    <basicUdiDi>B-14993478010103</basicUdiDi>
    <tradeName>LIPOSORBER D (DL-100)</tradeName>
    <deviceName>DL-100</deviceName>
    <manufacturerName>KANEKA Corporation</manufacturerName>
    <manufacturerSrn>JP-MF-000022143</manufacturerSrn>
    <authorisedRepresentativeName>Kaneka Medical Europe N.V.</authorisedRepresentativeName>
    <authorisedRepresentativeSrn>BE-AR-000010091</authorisedRepresentativeSrn>
    <riskClass>Sınıf IIb</riskClass>
    <legislation>MDD</legislation>
    <emdnCode>B030299</emdnCode>
    <emdnDescription>APHERESIS THERAPY DEVICES - OTHER</emdnDescription>
    <deviceStatus>Piyasada</deviceStatus>
    <reference>DL-100</reference>
    <placedOnMarketCountry>Germany</placedOnMarketCountry>
    <lastUpdated>2026-07-11T05:26:29.662Z</lastUpdated>
  </row>
  <row>
    <udiDi>08033772325356</udiDi>
    <basicUdiDi>803377232ADSH2</basicUdiDi>
    <tradeName>LA 25 LEUKOCYTE ADSORBER</tradeName>
    <deviceName>Leukocyte Adsorber</deviceName>
    <manufacturerName>Medica S.p.A.</manufacturerName>
    <manufacturerSrn>IT-MF-000025691</manufacturerSrn>
    <authorisedRepresentativeName></authorisedRepresentativeName>
    <authorisedRepresentativeSrn></authorisedRepresentativeSrn>
    <riskClass>Sınıf IIb</riskClass>
    <legislation>MDR 2017/745</legislation>
    <emdnCode>B030299</emdnCode>
    <emdnDescription>APHERESIS THERAPY DEVICES - OTHER</emdnDescription>
    <deviceStatus>Piyasada</deviceStatus>
    <reference>M03706</reference>
    <placedOnMarketCountry>Italy</placedOnMarketCountry>
    <lastUpdated>2026-07-03T05:13:38.693Z</lastUpdated>
  </row>
</eudamedExport>